El-Shafei, S., El-Belvesy, M., Zein El-Din, M., Abdou, M. (2004). Frequency of Arg972-IRS-1 Variant among Type I Diabetic Patients in El-Shatby Patients in El-Shatby Pediatric Hospital, Alexandria, Egypt. Journal of High Institute of Public Health, 34(3), 641-650. doi: 10.21608/jhiph.2004.187325
Sahar A. El-Shafei; Mervat F. El-Belvesy; Maged H. Zein El-Din; Magdy O. Abdou. "Frequency of Arg972-IRS-1 Variant among Type I Diabetic Patients in El-Shatby Patients in El-Shatby Pediatric Hospital, Alexandria, Egypt". Journal of High Institute of Public Health, 34, 3, 2004, 641-650. doi: 10.21608/jhiph.2004.187325
El-Shafei, S., El-Belvesy, M., Zein El-Din, M., Abdou, M. (2004). 'Frequency of Arg972-IRS-1 Variant among Type I Diabetic Patients in El-Shatby Patients in El-Shatby Pediatric Hospital, Alexandria, Egypt', Journal of High Institute of Public Health, 34(3), pp. 641-650. doi: 10.21608/jhiph.2004.187325
El-Shafei, S., El-Belvesy, M., Zein El-Din, M., Abdou, M. Frequency of Arg972-IRS-1 Variant among Type I Diabetic Patients in El-Shatby Patients in El-Shatby Pediatric Hospital, Alexandria, Egypt. Journal of High Institute of Public Health, 2004; 34(3): 641-650. doi: 10.21608/jhiph.2004.187325
Frequency of Arg972-IRS-1 Variant among Type I Diabetic Patients in El-Shatby Patients in El-Shatby Pediatric Hospital, Alexandria, Egypt
Several polymorphisms have been identified in the amino acid sequence of human insulin receptor substrate-1 [IRS-1]. The most prevalent one is glycine change to arginine at the codon 972 that was hypothesized to play a role in pancreatic ẞ-cell stimulus-coupled-insulin secretion and survival. The frequency of this variant among type I diabetic patients, their available normal sibs, and control subjects recruited from El-Shatby Pediatric Hospital, Alexandria University were studied. The result showed that the frequency of Arg972 IRS-1 variant was 14% in diabetic patients, 9.1% in normal sibs, and 4% in normal control subjects. Data revealed that Odds ratio showed that carriers of Arg972 IRS-1 variant had four times increased risk for developing the disease. In sibs, the risk is increased by three fold in carriers of this variant as compared to sibs with the wild allele. In spite being non-significant, the results of the present work suggest that Arg972 IRS-1 variant could be considered as a potential risk factor for developing type I diabetes although it was statistically non-significant, which may be attributed to the small sample size or methods of selection of cases.
View on SCiNiTO
Top